Achieve Life Sciences Inc expected to post a loss of 26 cents a share - Earnings Preview

Achieve Life Sciences

06/11/2024 05:03

* Achieve Life Sciences Inc  ACHV.OQ   ACHV.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 7 for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Achieve Life Sciences
Inc is
for a loss of 26 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is 13.00​, above​ its last closing price of $4.85.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.23       -0.23      -0.25     Missed  -7.9
 Mar. 31 0001  -0.25       -0.24      -0.26     Missed  -6.6
 Jan. 1 0001   -0.31       -0.31      -0.26     Beat    17.3​
 Jan. 1 0001   -0.37       -0.38      -0.34     Beat    10.2
 ​​Jun.        -0.41       -0.42      -0.43     Missed  -2
 30 2023                                                
 Mar. 31 2023  -0.68       -0.69      -0.50     Beat    27.1​
 Dec. 31 2022  -0.77       -0.83      -0.83     Met     0
 Sep. 30 2022  -1.14       -1.13      -1.35     Missed  -19.8
 This summary was machine generated November 6 at 05:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)